Acadia Healthcare Company
Acadia Healthcare Company, Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$3.3B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
35.3%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★★★☆position among all companies
9.4%
Capital efficiency
★☆☆☆☆position among all companies
-56.6%
Revenue and profit
Performance, financial position and capital allocation
Acadia Healthcare Company
Recent performance trends
Acadia Healthcare Company
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$2.3 billion | US$2.6 billion | US$2.9 billion | US$3.2 billion | US$3.3 billion |
| Net income | US$0.2 billion | US$0.3 billion | US$-21.67 million | US$0.3 billion | US$-1.1 billion |
| Total assets | US$4.8 billion | US$5.0 billion | US$5.4 billion | US$6.0 billion | US$5.5 billion |
| Shareholders' equity | US$2.5 billion | US$2.8 billion | US$2.8 billion | US$3.1 billion | US$1.9 billion |
| Net cash provided by (used in) operating activities | US$0.4 billion | US$0.4 billion | US$0.5 billion | US$0.1 billion | US$0.1 billion |
| Net cash provided by (used in) investing activities | US$1.0 billion | US$-0.3 billion | US$-0.4 billion | US$-0.7 billion | US$-0.6 billion |
| Net cash provided by (used in) financing activities | US$-1.6 billion | US$-0.1 billion | US$-62.70 million | US$0.6 billion | US$0.5 billion |
| Cash and cash equivalents | US$0.1 billion | US$97.65 million | US$0.1 billion | US$76.31 million | US$0.1 billion |
Revenue scale in the same industry
Acadia Healthcare Company
Health services: 20 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 HCA Healthcare US$75.6B
- 2 Tenet Healthcare US$21.3B
- 3 Universal Health Services US$17.4B
- … 10 companies
- 14 PACS Group US$5.3B
- 15 Ensign Group US$5.1B
- 16 Acadia Healthcare CompanyThis company US$3.3B
- 17 Surgery Partners US$3.3B
- 18 Exact Sciences US$3.2B
- … 2 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.6 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$0.1 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.1 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$1.9 billion | Consolidated | Disclosed |
| Net sales | US$3.3 billion | Consolidated | Disclosed |
| Net income | US$-1.1 billion | Consolidated | Disclosed |
| Total assets | US$5.5 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$50.03 million | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | 35.3% | Consolidated | Calculated |
| Net margin | -33.3% | Consolidated | Calculated |
| Return on equity | -56.6% | Consolidated | Calculated |